+ Filter
Loading...
Custom Services order now ship next day

Anti-TYK2 Recombinant Antibody Products

Loading...

Anti-TYK2 Products

View More Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


At Creative Biolabs, we are at the forefront of providing global researchers and pharmaceutical companies with premium anti-TYK2 recombinant antibody products. Engineered for unparalleled specificity and high affinity, our cutting-edge antibodies are indispensable tools for advancing drug discovery and development, facilitating crucial breakthroughs in inflammatory and autoimmune disease research worldwide.

TYK2: A Promising Target for Inflammatory and Autoimmune Therapies

TYK2 (Tyrosine Kinase 2) is a non-receptor tyrosine kinase, a key member of the Janus kinase (JAK) family, playing a pivotal role in the JAK-STAT signaling pathway. It specifically mediates signals from critical cytokines like IL-12, IL-23, and type I interferons, essential for regulating immune responses and inflammatory processes. Extensive research underscores TYK2's significance, particularly as a therapeutic target for autoimmune and inflammatory diseases, offering a selective pathway to modulate detrimental immune hyperactivity.

Alternative Names

Tyrosine kinase 2; non-receptor tyrosine-protein kinase TYK2; IMD35; JTK1; non-receptor tyrosine-protein kinase

Background

This gene encodes a member of the tyrosine kinase and, more specifically, the Janus kinases (JAKs) protein families. This protein associates with the cytoplasmic domain of type I and type II cytokine receptors and promulgate cytokine signals by phosphorylating receptor subunits. It is also component of both the type I and type III interferon signaling pathways. As such, it may play a role in anti-viral immunity. A mutation in this gene has been associated with hyperimmunoglobulin E syndrome (HIES) - a primary immunodeficiency characterized by elevated serum immunoglobulin E. [provided by RefSeq, Jul 2008].

Protein class

Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets

Predicted location

Intracellular

Single cell type specificity

Cell type enhanced (Distal tubular cells)

Immune cell specificity

Low immune cell specificity

Cell line specificity

Cell line enhanced (NB-4)

Interaction

Interacts with JAKMIP1 (PubMed:15277531, PubMed:20478313). Interacts with PIK3R1; this interaction is important for cell migration (PubMed:10995743). (Microbial infection) Interacts with Epstein-Barr virus protein LMP1; this interaction inhibits TYK2-mediated interferon signaling. (Microbial infection) Interacts with papillomavirus-18 protein E6; this interaction impairs JAK-STAT activation by interferon-alpha.

Molecular function

Kinase, Transferase, Tyrosine-protein kinase

More Types Infomation

Anti-TYK2 rAb Products

Creative Biolabs' anti-TYK2 recombinant antibodies are engineered with unparalleled precision, leveraging cutting-edge genetic techniques to deliver exceptional purity and unwavering lot-to-lot consistency, ensuring reliable and reproducible results. These antibodies offer superior specificity and binding affinity, critical for reliable and reproducible results in diverse research applications, from preclinical studies to therapeutic development. Their recombinant nature guarantees high functional activity and reduced batch variation compared to traditional polyclonal antibodies.

Table 1. Featured anti-TYK2 recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
ZG-0487F Mouse Anti-TYK2 Recombinant Antibody (ZG-0487F) Human Mouse IgG WB, ELISA
MRO-2247-CN Rabbit Anti-TYK2 Polyclonal Antibody (MRO-2247-CN) Human, Mouse, Rat Rabbit IgG WB, IF, IHC, FC
MOB-2052CT Recombinant Mouse anti-Human TYK2 Monoclonal antibody (EML1829) Human Mouse IgG IHC-P, WB
MOR-3732 Rabbit Anti-TYK2 Recombinant Antibody (clone DS3732AB) Human Rabbit IgG WB, IP, IHC
VS7-0425-WR1075 Mouse Anti-TYK2 Monoclonal Antibody (clone 8G8B3) Human Mouse IgG1 WB, ELISA

Creative Quality Control

Our anti-TYK2 recombinant antibody products undergo rigorous, multi-faceted quality control measures. We employ comprehensive analytical methods, including ELISA, Western Blot, and flow cytometry, to verify target specificity, binding kinetics, and functional activity. This stringent quality assurance process ensures that every antibody lot meets the highest industry standards, providing researchers with dependable and validated tools for their critical experiments.

Fig.1 WB analysis. (Creative Biolabs Original)Fig.1 WB analysis of anti-TYK antibody
(Cat# ZG-0487F, Creative Biolabs).

Customer Reviews

Excellent
A**a Sh***a
Rabbit Anti-TYK2 Polyclonal Antibody (MRO-2247-CN) (MRO-2247-CN)
The anti-TYK2 recombinant antibody from Creative Biolabs significantly accelerated our in vitro signaling pathway studies. Its high specificity and low background noise were particularly impressive, allowing for crystal-clear data interpretation. We achieved results faster than anticipated, which is invaluable in our fast-paced research environment.
10/May/2024
Excellent
M**k Je***n
Mouse Anti-TYK2 Recombinant Antibody (ZG-0487F) (ZG-0487F)
Our team utilized Creative Biolabs' anti-TYK2 antibody for immunohistochemistry in complex tissue samples. The consistent performance across multiple batches was outstanding, yielding precise and reproducible staining. This consistency is crucial for our translational research, and it has become our go-to reagent for TYK2-related investigations.
5/Jun/2024
Excellent
Ch*n L*
Rabbit Anti-TYK2 Recombinant Antibody (clone DS3732AB) (MOR-3732)
For our therapeutic antibody development program, the anti-TYK2 recombinant antibody's application in functional assays was critical. It demonstrated potent neutralizing activity against TYK2-mediated signaling, validating our experimental models. The ease of use and the detailed product documentation also streamlined our workflow considerably, contributing to a smooth research progression.
22/Apr/2025

rAb Production

Our anti-TYK2 recombinant antibodies are produced through a robust and scalable manufacturing process within state-of-the-art facilities. Leveraging advanced bioreactor technology and proprietary purification techniques, we ensure consistent high yields of pure, active antibody. This optimized production workflow allows us to efficiently meet the demands of both small-scale research and larger preclinical studies, ensuring timely access to essential reagents.

Featured Anti-TYK2 Recombinant Antibody Production PlatformsFig.2 Milligram-scale. (Creative Biolabs Original)
Fig.2 Milligram-scale anti-TYK2 recombinant antibody production.

Fig.3 Gram-scale. (Creative Biolabs Original)Fig.3 Gram-scale anti-TYK2 recombinant antibody production.

rAb Modalities

Our anti-TYK2 recombinant antibodies are offered with a range of formats and modifications, providing versatile options for your research needs. This adaptability allows researchers to select the optimal tool for their specific experimental needs, enhancing research efficiency.

Fig.4 TYK2 antibody production and modalities. (Creative Biolabs Original)Fig.4 Full-length anti-TYK2 recombinant antibody production and modalities.

TYK2-Targeted Drug Information

Table 2. Public drug targeting TYK2.

Company Research phase Classification Condition
Hangzhou Highlightll Pharmaceutical (Originator)
TLL Pharmaceutical (Originator)
Phase III Atopic dermatitis
Autoimmune disease
Plaque psoriasis
Rheumatoid arthritis
Ulcerative colitis
Urticaria
VivaVision Biotech (Originator) Phase II Uveitis
TechnoDerma Medicines (Originator) Phase II Atopic dermatitis
InnoCare (Originator) Phase II Autoimmune disease
Inflammatory bowel disease
Plaque psoriasis
Psoriasis
InnoCare (Originator)
InnoCare Pharma (InnoCare)
Phase II Atopic dermatitis
Autoimmune disease
Psoriasis
Alumis (Originator) Phase II Plaque psoriasis
Systemic lupus erythematosus
Uveitis
Ventyx Biosciences (Originator) Phase II Arthritis, psoriatic
Autoimmune disease
Crohn's disease
Inflammatory bowel disease
Plaque psoriasis
Galapagos (Originator)
Gilead
Phase II Arthritis, psoriatic
Dermatomyositis
Plaque psoriasis
Systemic lupus erythematosus
Ulcerative colitis
Oncostellae (Originator) Phase I/II Ulcerative colitis
Bristol-Myers Squibb (Originator) Phase I Prodrugs Neuroinflammation
Alumis (Originator) Phase I Multiple sclerosis
Neurodegeneration
Neuroinflammation
Parkinson's disease
Biohaven
Guangzhou Gaoling Pharmaceuticals (Hangzhou Highlightll Pharmaceutical)
Hangzhou Highlightll Pharmaceutical (Originator)
Phase I Dementia, Alzheimer type
Multiple sclerosis
Neuroinflammation
Neurological Disorders
Parkinson's disease

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

Empowering scientific breakthroughs starts with superior reagents. Creative Biolabs' anti-TYK2 recombinant antibodies offer the precise targeting and dependable performance critical for your most ambitious research. Browse our full product line and let our expertise enhance your studies. Reach out to us for more details or to discuss your project's unique demands.

Go to compare

Go to compare